Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Esophageal Neoplasms × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

OTHER 57 INDUSTRY 16 NETWORK 6 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 10 Colorectal Neoplasms 7 Rectal Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 2 Immunotherapy 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Pancreatic Neoplasms 1 Mid-low Rectal Cancer 1 Locally Advanced Rectal Cancer With Liver Metastases 1 Locally Advanced Rectal Cancer 1 Liver Metastases of Colorectal Cancer 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Colorectal Cancer Liver Metastasis 1 Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1 Adenocarcinoma 1

Interventions

Paclitaxel 7 Cisplatin 5 Radiation 4 Carboplatin 4 tislelizumab 3 Surgical Procedures, Operative 3 Radiotherapy 3 Immune Checkpoint Inhibitors 3 Capecitabine 3 camrelizumab 2 Platinum Compounds 2 Endoscopic Mucosal Resection 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 nedaplatin 1 Tranexamic Acid 1 Thalidomide 1 TP protocol 1 Stents 1 Standard of Care 1 Oxaliplatin 1 Nutrition Assessment 1 Neoadjuvant Therapy 1 Muscle Stretching Exercises 1 Indocyanine Green 1 Heart Rate 1 Fluorouracil 1 Exercise 1 Epinephrine 1 Elective Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01843829 2014-03-24

NeoSCOPE

Velindre NHS Trust

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡